Genome & Company
Venture Capital
South Korean KOSDAQ-listed clinical-stage biotech making strategic equity investments in complementary microbiome and immuno-oncology companies.
Seoul, South Korea · 1+ investments · 1 portfolio companies
Growth
Biotech
immuno-oncology
microbiome
- Headquarters
- Seoul, South Korea
- Website
- genomeandcompany.com
- Portfolio Company
- 1
- Total Investment
- 1
- Last Investment
- Aug 2020
- Geographic Focus
- South Korea, United States
Investment Thesis
Strategic investments in microbiome and cancer therapeutics companies that complement Genome & Company's own drug pipeline.
Genome & Company is a Venture Capital firm based in Seoul, South Korea. It has made 1 investment in Biotech and immuno-oncology, including Scioto Biosciences.
Portfolio1
Co-investors1
Sign up to view co-investors
1 co-investors across 1 shared portfolio company — who they back alongside, and how often they lead.
Accelerator ×1
Investment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.
Your firm? Embed this profile
Add the live badge to your site — it stays current as your portfolio data updates.
<a href="https://indexed.vc/investors/genome-company"><img src="https://indexed.vc/api/badge/investor/genome-company" alt="Genome & Company on Indexed.vc" width="260" height="76" /></a>